salvinorin a has been researched along with 1-(3-trifluoromethylphenyl)piperazine in 1 studies
| Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (1-(3-trifluoromethylphenyl)piperazine) | Trials (1-(3-trifluoromethylphenyl)piperazine) | Recent Studies (post-2010) (1-(3-trifluoromethylphenyl)piperazine) |
|---|---|---|---|---|---|
| 247 | 7 | 128 | 281 | 7 | 23 |
| Protein | Taxonomy | salvinorin a (IC50) | 1-(3-trifluoromethylphenyl)piperazine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.57 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.57 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.29 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.61 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.15 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.039 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuddy, ML | 1 |
1 review(s) available for salvinorin a and 1-(3-trifluoromethylphenyl)piperazine
| Article | Year |
|---|---|
Common drugs of abuse--Part II.
Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States | 2004 |